Apply for hundreds of jobs at recently funded biopharma and therapeutics startups. Startups range from Series A stage to companies that have recently gone public.
If you have questions or feedback, feel free to contact us. If you're interested in getting an email when we post new articles or job posts, sign up below. We usually send one email every 2-3 weeks.
| Job title | Job location | Company name | Last funding amount ($M) | Last funding round | Last funding date | Therapeutic areas |
|---|---|---|---|---|---|---|
| RESEARCH ASSOCIATE – ASSAY DEVELOPMENT | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Research Associate / Sr Research Associate – Cell Therapy / Discovery Biology | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Scientist / Sr Scientist – Gene Therapy | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Scientist – Cell Therapy / Discovery Biology | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Research Associate / Sr Research Associate – Pharmacology | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Bioinformatics Engineer – Research | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| IT Support Engineer – Information Technology | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Scientist – Cell Therapy | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Research Associate / Sr Research Associate – Cell Therapy | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Research Associate / Sr Research Associate – Gene Therapy | South San Francisco, CA | Ambys Medicines | $60 | Series A | 08/08/2018 | Liver disease, Regenerative medicine |
| Director Data Management & Bio-statistics | Amsterdam, Netherlands | AM-Pharma | $133 | Late stage | 07/16/2019 | Renal disease |
| Director Finance | Amsterdam, Netherlands | AM-Pharma | $133 | Late stage | 07/16/2019 | Renal disease |
| VP Business Development & Corporate Counsel | Amsterdam, Netherlands | AM-Pharma | $133 | Late stage | 07/16/2019 | Renal disease |
| VP Manufacturing & Supply Chain Management | Amsterdam, Netherlands | AM-Pharma | $133 | Late stage | 07/16/2019 | Renal disease |
| Manager Of Regulatory | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Biostatistician | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Associate Director / Director, Medical Writing | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Senior Scientist | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Scientist | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Director, Information Technology | Cambridge, MA | Avrobio | $99 | IPO | 06/20/2018 | Rare disease |
| Accounting Manager | Lexington, MA | Bicycle Therapeutics | $60 | IPO | 05/22/2019 | Oncology, Ophthalmology |
| Clinical Scientist, Associate Director/Director | Lexington, MA | Bicycle Therapeutics | $60 | IPO | 05/22/2019 | Oncology, Ophthalmology |
| Head Of Investor Relations And Corporate Communications | Lexington, MA | Bicycle Therapeutics | $60 | IPO | 05/22/2019 | Oncology, Ophthalmology |
| Medical Writer, Associate Director | Lexington, MA | Bicycle Therapeutics | $60 | IPO | 05/22/2019 | Oncology, Ophthalmology |
| Medical Director | Lexington, MA | Bicycle Therapeutics | $60 | IPO | 05/22/2019 | Oncology, Ophthalmology |
| Director / Senior Director, Clinical Development | San Francisco, CA | BlackThorn Therapeutics | $76 | Series B | 06/13/2019 | Neurology |
| Principal Research Scientist, Neuroscience and Machine Learning | San Francisco, CA | BlackThorn Therapeutics | $76 | Series B | 06/13/2019 | Neurology |
| Associate Director, Neurobiology | San Francisco, CA | BlackThorn Therapeutics | $76 | Series B | 06/13/2019 | Neurology |
| Senior Research Associate, in vitro Pharmacology | San Francisco, CA | BlackThorn Therapeutics | $76 | Series B | 06/13/2019 | Neurology |
| Clinical Scientist | San Francisco, CA | BlackThorn Therapeutics | $76 | Series B | 06/13/2019 | Neurology |
| Clinical Supply, Associate Director - Associate Director or Senior Manger | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Medical Information and Document Management，Senior Manager | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Pharmacovigilance (PV) - Senior Director | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Quality and Risk Management - Director – Senior Director | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| SAS Programming - Senior Manager | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Trial Assistant | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Data Management - Senior Manager/Manager | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Sourcing Management - Senior Manager | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Research Physician - Associate Director | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Research - Senior Manager to Assistant Director | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Development Project/Program Manager | Durham, NC, Beijing, China or Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Clinical Development - Director or Senior Director | Beijing / Shanghai, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Discovery and Translational Sciences - Associate Director/Director | Durham, NC | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Government Affairs/Public Relations - Senior Director | Beijing, China | Brii Bio | $260 | Series A | 05/24/2018 | Undisclosed |
| Vice President, Clinical Operations And Development | Cambridge, MA | Cadent Therapeutics | $40 | Series B | 11/15/2018 | Neurology |
| Director/Sr. Director/VP Finance and Accounting | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Computational Chemist | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Associate Director, Director, Translational Sciences | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Associate Scientist/Sr. Associate Scientist, Discovery Biology | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Senior Research Scientist, Biochemistry | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Scientist I, Biology | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Manager/Associate Director/Director, Program Management | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Research Associate--Cell Lines, Biology | Cambridge, MA | Casma Therapeutics | $58 | Series A | 05/03/2018 | Neurodegenerative, Rare disease |
| Biology Associate Director/Director | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Associate Computational Biologist | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Research Associate, Biology | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Research Associate/Senior Research Associate, Protein Sciences | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Senior Research Associate, Biology | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Senior Scientist, Structural Biology | Cambridge, MA | Cedilla Therapeutics | $56 | Series A | 04/24/2018 | Neurology, Oncology, Rare disease |
| Senior Scientists, Computational Biology | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Assoc. Director / Director / Sr. Director of Finance | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Head of Single Cell Genomics | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Research Associate, Single Cell Genomics | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Research Associates/Senior Research Associates, Genetic Perturbation | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Scientist, Single Cell Genomics | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Research Associate, In Vivo Pharmacology | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Research Associate/Senior Research Associate, Tissue Analysis | Cambridge, MA | Celsius Therapeutics | $65 | Series A | 05/15/2018 | Autoimmune, Oncology |
| Scientific Expert, In Vivo Pharmacology | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| Associate Director/Director, Protein Science | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| General Lab Manager, Therapeutic Logistics and Operations | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| Scientific Expert, Cell Engineering | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| Director/Senior Director Process Development | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| Scientific Expert, iPSC | Philadelphia, PA | Century Therapeutics | $211 | IPO | 06/17/2021 | Hematology, Oncology, Immunology |
| RA/Scientist/Sr. Scientist – cell biology (Multiple Positions) | Cambridge, MA | Comet Therapeutics | $28 | Series A | 06/19/2019 | Metabolic disorders, Neurodegenerative, Neurology, Immunology |
| Vice President, Clinical Development | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Research Associate, Histology | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Research Associate | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Medical Director, Clinical Development | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Statistical Genetics Consultant | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Director of Process Development | Boston, MA | Decibel Therapeutics | $127 | IPO | 02/11/2021 | Otology |
| Biology Sr. Research Associate | Cambridge, MA | Dyne Therapeutics | $232 | IPO | 09/16/2020 | Neurology, Rare disease |
| Biochemistry Sr. Research Associate | Cambridge, MA | Dyne Therapeutics | $232 | IPO | 09/16/2020 | Neurology, Rare disease |
| Research Associate/Senior Research Associate, Technology Team | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Research Associate/Senior Research Associate, Molecular Biology | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Research Associate/Senior Research Associate, Assay Development | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Quality Assurance (QA) Specialist/Sr. Specialist | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Quality Assurance (QA) Manager, CMO | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Quality Assurance Manager, Quality Systems | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Process Development Associate / Sr. PD Associate, CMC Analytical Development | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Process Development Associate / Senior PD Associate, Cell Culture | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Process Development Associate/Analyst | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Patent Agent/Patent Counsel | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Husbandry Technician | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| General Considerations + Future Opportunities | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Director/Sr. Director of Intellectual Property | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Director/Associate Director, Regulatory CMC | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Associate Director of Analytical Development | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Senior Research Associate/Scientist, Upstream Production | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Senior Quality Control (QC) Analyst | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Senior Research Associate/Scientist, Downstream Purification | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Senior Laboratory Operations Specialist | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Scientist, Molecular Biology | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Research Associate/Senior Research Associate, Technology Team | South San Francisco, CA | Encoded Therapeutics | $104 | Series C | 06/26/2019 | Epilepsy, Neurology, Rare disease |
| Scientist, Bioinformatics/Proteomics | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Senior / Principal Scientist, Computational Chemist | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Scientist / Senior Scientist, Discovery Biology | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Director / Associate Director, Chemical Biology | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Scientist / Senior Scientist, Cheminformatics | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Scientist / Senior Scientist, Disease Biology | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Software Engineer / Cloud Architect / System Administrator | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Director / Associate Director, Discovery Biology | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Scientist I/II, Medicinal Chemistry | South San Francisco, CA | Frontier Medicines | $67 | Series A | 06/25/2019 | Oncology |
| Research Fellow, Discovery | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Scientist, Target Biology and Gene Regulation | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Director, Corporate Communications and Investor Relations | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Computational Biologist - Molecular Profiling | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Computational Biologist - Data Science | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Associate Director/Director, Biostatistics | Cambridge, MA | Fulcrum Therapeutics | $72 | IPO | 07/17/2019 | Neurodegenerative, Neurology, Rare disease |
| Associate Director / Director, Drug Product Formulation | Cambridge, MA | Generation Bio | $200 | IPO | 06/11/2020 | Rare disease |
| Scientist, Delivery | Cambridge, MA | Generation Bio | $200 | IPO | 06/11/2020 | Rare disease |
| Scientist / Senior Scientist, Retinal Biology | Cambridge, MA | Generation Bio | $200 | IPO | 06/11/2020 | Rare disease |
| (Senior) Research Associate, Delivery | Cambridge, MA | Generation Bio | $200 | IPO | 06/11/2020 | Rare disease |
| Director / Associate Director, Biology/Pharmacology | Cambridge, MA | HotSpot Therapeutics | $45 | Series A | 07/17/2018 | Autoimmune, Liver disease, Oncology |
| Scientist, Upstream Process Sciences | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Biomarker Scientist | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Research Associate/Senior Research Associate, Cell-line Development | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Senior Research Associate, Discovery Biology | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Senior Research Associate – Immunology and Cell Biology | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Senior Research Associate, Upstream Process Sciences | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| Process Analytical Scientist | Mountain View, CA | IGM Biosciences | $175 | IPO | 09/17/2019 | Oncology |
| (Senior) Genomic Data Scientist - Computational Biologist | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| (Senior) Machine Learning Scientist - Computer Vision / Microscopy | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Data Engineer | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Senior Research Associate - Molecular Biology | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| VP / SVP, Machine Learning & Data Science | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| (Senior) Clinical Data Scientist - Biostatistician | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| (Senior) Data Scientist - Statistical Geneticist | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Head of Data Engineering | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Head of Disease Model Systems | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Lab Operations Manager | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Machine Learning Engineer / Senior Machine Learning Engineer | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Senior Automation Engineer | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Research Associate - Microscopy | South San Francisco, CA | insitro | $100 | Series A | 05/02/2018 | Undisclosed |
| Neuroimaging Scientist | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Biology Research Associate | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Pharmacology In Vivo Research Associate | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| In Vivo Biology Scientist | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Director, In Vitro Pharmacology | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Biomarker Research Associate | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Biology In Vivo Research Associate | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Computational Geneticist | New York | Kallyope | $66 | Series B | 02/22/2018 | Metabolic disorders, Neurology |
| Research Scientist, Bioinformatics | Cambridge, MA | Kronos Bio | $250 | IPO | 10/08/2020 | Oncology |
| Senior Research Scientist / Team Lead, Protein Degradation - Medicinal Chemistry | Cambridge, MA | Kronos Bio | $250 | IPO | 10/08/2020 | Oncology |
| Senior Research Scientist / Team Lead, Drug Discovery – Cancer Biology | Cambridge, MA | Kronos Bio | $250 | IPO | 10/08/2020 | Oncology |
| Laboratory Manager | Cambridge, MA | Kronos Bio | $250 | IPO | 10/08/2020 | Oncology |
| Project Leader (Principal Scientist To Director), Biology | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Computational Drug Discovery Scientist (Principal Scientist To Senior Director) | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Senior RA, Discovery Immunology | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| RA/SRA, Discovery | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Scientist To Senior Scientist, Proteomics | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| DMPK Leader | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Scientist Or Senior Scientist, Discovery | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Principal Scientist To Director, Discovery | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Senior Scientist, Biology | Cambridge, MA | Kymera Therapeutics | $173 | IPO | 08/20/2020 | Dermatology, Inflammation, Oncology, Immunology |
| Associate Director / Director, Corporate Communications | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Senior Research Associate, Immunology/Stem Cell Biology | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Research Associate/Sr. Research Associate, Bioconjugates | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Associate Director, People And Culture | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Associate Director/Director, Program Management | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Senior Manager/Associate Director, Regulatory Affairs | Cambridge, MA | Magenta Therapeutics | $100 | IPO | 06/20/2018 | Bone marrow transplant |
| Senior Scientist / Scientist, In Vitro Pharmacology | South San Francisco, CA | Maze Therapeutics | $191 | Series A | 02/28/2019 | Rare disease, Undisclosed |
| Research Associate / Senior Research Associate, Cell Biology | San Francisco, CA | Maze Therapeutics | $191 | Series A | 02/28/2019 | Rare disease, Undisclosed |
| Research Associate / Senior Research Associate, Functional Genomics | South San Francisco, CA | Maze Therapeutics | $191 | Series A | 02/28/2019 | Rare disease, Undisclosed |
| Senior / Principal Scientist Biomarker Development, Biology | South San Francisco, CA | Maze Therapeutics | $191 | Series A | 02/28/2019 | Rare disease, Undisclosed |
| Senior Bioinformatics Software Engineer | South San Francisco, CA | Maze Therapeutics | $191 | Series A | 02/28/2019 | Rare disease, Undisclosed |
| Director, Contracts Management / Procurement | Cambridge, MA | Nimbus Therapeutics | $65 | null | 06/05/2018 | Autoimmune, Infectious disease, Metabolic disorders, Oncology |
| SENIOR DIRECTOR, STRUCTURAL BIOLOGY AND BIOPHYSICS | Cambridge, MA | Nimbus Therapeutics | $65 | null | 06/05/2018 | Autoimmune, Infectious disease, Metabolic disorders, Oncology |
| Director, Immuno-Oncology | Cambridge, MA | Nimbus Therapeutics | $65 | null | 06/05/2018 | Autoimmune, Infectious disease, Metabolic disorders, Oncology |
| DIRECTOR, BIOCHEMISTRY | Cambridge, MA | Nimbus Therapeutics | $65 | null | 06/05/2018 | Autoimmune, Infectious disease, Metabolic disorders, Oncology |
| DIRECTOR, ONCOLOGY | Cambridge, MA | Nimbus Therapeutics | $65 | null | 06/05/2018 | Autoimmune, Infectious disease, Metabolic disorders, Oncology |
| Director of People | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| High Throughput Flow Cytometry Analyst | Remote | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Research Scientist - HTS Team | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Senior Scientist - Immuno-oncology | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Senior Scientist - Translational Oncology | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Full Stack Software Engineer | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Automation Engineer | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Senior Software Engineer, Bioinformatics | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| Data Entry Specialist | Foster City, CA | Notable Labs | $40 | Series B | 07/16/2019 | Oncology |
| STRATEGY & BUSINESS DEVELOPMENT | Daejeon, South Korea | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| SCIENTIST, CANCER BIOLOGY | Daejeon, South Korea | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| RESEARCH SCIENTIST, CANCER BIOLOGY OR RARE DISEASES | Cambridge, MA | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| SCIENTIST/SENIOR SCIENTIST, DISCOVERY BIOCONJUGATION CHEMISTRY | Cambridge, MA | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| PROTEIN ENGINEER | Daejeon, South Korea | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| BIOANALYTICAL SCIENTIST | Daejeon, South Korea | Orum Therapeutics | $30 | Series B | 07/17/2019 | Oncology, Rare disease |
| Senior Director, Regulatory Affairs | Redwood City, CA | Pliant Therapeutics | $144 | IPO | 06/02/2020 | Fibrosis, Liver disease, Pulmonology |
| Associate Director/Director – Toxicology | Redwood City, CA | Pliant Therapeutics | $144 | IPO | 06/02/2020 | Fibrosis, Liver disease, Pulmonology |
| Medical Director | Redwood City, CA | Pliant Therapeutics | $144 | IPO | 06/02/2020 | Fibrosis, Liver disease, Pulmonology |
| Senior Clinical Research Associate | Redwood City, CA | Pliant Therapeutics | $144 | IPO | 06/02/2020 | Fibrosis, Liver disease, Pulmonology |
| Sr. Research Associate, Medicinal Chemistry | Redwood City, CA | Pliant Therapeutics | $144 | IPO | 06/02/2020 | Fibrosis, Liver disease, Pulmonology |
| Discovery Bioanalytical Scientist | Wilmington, DE | Prelude Therapeutics | $158 | IPO | 09/24/2020 | Oncology |
| Biology Drug Discovery - Research Associate | Wilmington, DE | Prelude Therapeutics | $158 | IPO | 09/24/2020 | Oncology |
| Medicinal Chemistry - Research Scientist | Wilmington, DE | Prelude Therapeutics | $158 | IPO | 09/24/2020 | Oncology |
| Research Associate, Biology | Wilmington, DE | Prelude Therapeutics | $158 | IPO | 09/24/2020 | Oncology |
| Machine Learning Researcher | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Sr. Data Scientist- Image Analysis and Quality | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Director of Regulatory Affairs | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Data Scientist- Innovation and Assay Development | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Communications and Content Manager | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Automation Engineer | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Machine Learning Engineer | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Research Associate- Innovation Biology | Salt Lake City, UT | Recursion Pharmaceuticals | $436 | IPO | 04/15/2021 | Oncology, Rare disease |
| Procurement Specialist | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Scientist/Senior Scientist Mass Spectrometry | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Director, Medicinal Chemistry | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Scientist, Translational Medicine | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Computational Chemist | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Staff Accountant | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Research Associate, In Vitro Biology (Contractor) | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Early Development, Sr. Program Manager | Cambridge, MA | Relay Therapeutics | $400 | IPO | 07/15/2020 | Oncology |
| Director, Biostatistics | Woburn, MA | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Senior Director, Biostatistics | Woburn, MA | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Accounts Payable Specialist | Framingham, MA | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Clinical Trial Associate | N/A | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Medical Director | Woburn, MA | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Clinical Operations Finance Business Partner | Woburn, MA | Replimune | $100 | IPO | 07/19/2018 | Oncology |
| Director, Clinical Diagnostics | Redwood City, CA | Revolution Medicines | $238 | IPO | 02/12/2020 | Oncology |
| Senior Scientist, Toxicology, Non-Clinical Development & Clinical Pharmacology | Redwood City, CA | Revolution Medicines | $238 | IPO | 02/12/2020 | Oncology |
| Scientist II / Senior Scientist I, Process R&D – CMC | Redwood City, CA | Revolution Medicines | $238 | IPO | 02/12/2020 | Oncology |
| Associate Director, Analytical Development – CMC | Redwood City, CA | Revolution Medicines | $238 | IPO | 02/12/2020 | Oncology |
| Associate Director/Director, Cancer Pharmacology | Redwood City, CA | Revolution Medicines | $238 | IPO | 02/12/2020 | Oncology |
| Vice President, Biology and Translational Sciences | Cambridge, MA | Rheos Medicines | $60 | Series A | 03/22/2018 | Autoimmune, Inflammation, Oncology |
| Sr.RA/Associate Scientist, Lead Discovery | Cambridge, MA | Rheos Medicines | $60 | Series A | 03/22/2018 | Autoimmune, Inflammation, Oncology |
| Scientist, Computational Biology and Bioinformatics | Cambridge, MA | Rheos Medicines | $60 | Series A | 03/22/2018 | Autoimmune, Inflammation, Oncology |
| Senior Scientist, Metabolomics | Cambridge, MA | Rheos Medicines | $60 | Series A | 03/22/2018 | Autoimmune, Inflammation, Oncology |
| Medical Director, Clinical Development | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Scientist, Translational Science | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Director, Clinical Operations | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Director, Business Development | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Director, Program Management | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Senior Corporate Counsel | Cambridge, MA | Surface Oncology | $108 | IPO | 04/18/2018 | Oncology |
| Lead Molecular Lab Specialist | Baltimore, MD | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Developer, LIMS | Baltimore, MD | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Senior Bioinformatic Scientist | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Principal/Senior Scientist, Computational Biology | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Architect, Software Engineering | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Principal/Senior Scientist, Computational Biology | Baltimore, MD | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Director of Business Development | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Data Scientist | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Principal/Senior Scientist, Genomics Assay Development | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Principal/Senior Scientist, Protein Diagnostics | Cambridge, MA | Thrive Earlier Detection | $110 | Series A | 05/30/2019 | Oncology |
| Research Scientist | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Scientist, Analytical CMC | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Associate Director/Director, DMPK | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Associate Director/Director Regulatory Affairs CMC | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Scientist, CMC | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| CMC, Scientist | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Senior Scientist Pulmonary Biology | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Sr. Scientist/Sr Engineer Technical Transfer | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Scientist Pulmonary Biology | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Sr. Scientist, Analytical CMC | Lexington, MA | Translate Bio | $121 | IPO | 06/27/2018 | Liver disease, Neurology, Oncology, Ophthalmology, Rare disease |
| Medical Director | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Medical Director | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Senior Research Associate/Associate Scientist – Molecular Biology | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Scientist I/II - Bioassay (Immunology) | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Scientist I/II, Molecular Biology and Virology | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Senior Director / Vice President of Process and Analytical Development | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Head of Quality (Senior Director/Vice President) | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Associate Scientist, Translational Medicine | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Scientist II/Senior Scientist, Translational Medicine | Cambridge, MA | Unum Therapeutics | $69 | IPO | 03/28/2018 | Oncology |
| Associate Scientist/Scientist, Assay Development | Cambridge, MA | Xilio Therapeutics | $30 | IPO | 10/21/2021 | Oncology, Immunology |
| Scientist/Sr. Scientist, Immunology | Cambridge, MA | Xilio Therapeutics | $30 | IPO | 10/21/2021 | Oncology, Immunology |
| Senior Scientist, Protein Production | Cambridge, MA | Xilio Therapeutics | $30 | IPO | 10/21/2021 | Oncology, Immunology |
| Scientist, Protease Biology | Cambridge, MA | Xilio Therapeutics | $30 | IPO | 10/21/2021 | Oncology, Immunology |
Top biotech venture capital funds of 2018
Recently funded biopharma startups
Biopharma VC basics: how do VCs work?
Valuing drugs and biotech companies
Then consider joining our mailing list. I periodically publish data-driven articles on the biotech startup and VC world.